Cormorant Asset Management, LP Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$705.2B
Holdings
84
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (84 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ALDER BIOPHARMACEUTICALS INC | 1,689,071 | $42.2B | 5.98% | |
| 2 | NVROEURNEVRO CORP | 491,044 | $36.2B | 5.14% | |
| 3 | HRTXHERON THERAPEUTICS INC | 1,771,263 | $32.0B | 4.53% | |
| 4 | —TESARO INC | 362,875 | $30.5B | 4.33% | |
| 5 | NKTREURNEKTAR THERAPEUTICS | 2,022,879 | $28.8B | 4.08% | |
| 6 | NERVGBPMINERVA NEUROSCIENCES INC | 2,800,000 | $28.6B | 4.05% | |
| 7 | TBPHTHERAVANCE BIOPHARMA INC | 1,118,372 | $25.4B | 3.60% | |
| 8 | SG7SAGE THERAPEUTICS INC | 730,000 | $22.0B | 3.12% | |
| 9 | EGRXEAGLE PHARMACEUTICALS INC | 505,995 | $19.6B | 2.78% | |
| 10 | MGNXMACROGENICS INC | 707,978 | $19.1B | 2.71% | |
| 11 | —VITAE PHARMACEUTICALS INC | 1,754,795 | $18.9B | 2.68% | |
| 12 | GLPGGALAPAGOS NV | 334,044 | $18.3B | 2.60% | |
| 13 | NBIXNEUROCRINE BIOSCIENCES INC | 398,301 | $18.1B | 2.57% | |
| 14 | OMEROMEROS CORP | 1,710,000 | $18.0B | 2.55% | |
| 15 | ACRSACLARIS THERAPEUTICS INC | 901,286 | $16.6B | 2.36% | |
| 16 | —PROTEOSTASIS THERAPEUTICS IN | 1,354,339 | $16.4B | 2.33% | |
| 17 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 1,988,208 | $13.9B | 1.98% | |
| 18 | CLLSCELLECTIS S A | 498,117 | $13.2B | 1.88% | |
| 19 | ARDXARDELYX INC | 1,499,226 | $13.1B | 1.86% | |
| 20 | —CHINA BIOLOGIC PRODS INC | 112,867 | $12.0B | 1.70% | |
| 21 | —QUOTIENT LTD | 1,537,717 | $11.9B | 1.69% | |
| 22 | SRNESORRENTO THERAPEUTICS INC | 2,121,013 | $11.9B | 1.68% | |
| 23 | NVAXNOVAVAX INC | 1,619,608 | $11.8B | 1.67% | |
| 24 | ALNYALNYLAM PHARMACEUTICALS INC | 200,355 | $11.1B | 1.58% | |
| 25 | CHRSCOHERUS BIOSCIENCES INC | 576,106 | $9.7B | 1.38% | |
| 26 | —MYOKARDIA INC | 758,290 | $9.4B | 1.33% | |
| 27 | —PORTOLA PHARMACEUTICALS INC | 396,000 | $9.3B | 1.33% | |
| 28 | DVAXDYNAVAX TECHNOLOGIES CORP | 635,000 | $9.3B | 1.31% | |
| 29 | —RELYPSA INC | 450,000 | $8.3B | 1.18% | |
| 30 | WVEWAVE LIFE SCIENCES LTD | 394,407 | $8.2B | 1.16% | |
| 31 | GBYSANGAMO BIOSCIENCES INC | 1,402,331 | $8.1B | 1.15% | |
| 32 | DC4DEXCOM INC | 100,000 | $7.9B | 1.12% | |
| 33 | —ACHILLION PHARMACEUTICALS IN | 1,006,128 | $7.8B | 1.11% | |
| 34 | —INC RESH HLDS INC CL A | 200,000 | $7.6B | 1.08% | |
| 35 | MCRB1EURSERES THERAPEUTICS INC | 253,064 | $7.4B | 1.04% | |
| 36 | —ADVAXIS INC | 809,804 | $6.6B | 0.93% | |
| 37 | AGENEURAGENUS INC | 1,578,106 | $6.4B | 0.91% | |
| 38 | SCTLRECRO PHARMA INC | 778,288 | $6.2B | 0.88% | |
| 39 | —FORWARD PHARMA A/S | 339,175 | $6.2B | 0.87% | |
| 40 | CRBPEURCORBUS PHARMACEUTICALS HLDGS | 2,000,000 | $6.0B | 0.85% | |
| 41 | RAREULTRAGENYX PHARMACEUTICAL INC | 110,842 | $5.4B | 0.77% | |
| 42 | COLLCOLLEGIUM PHARMACEUTICAL INC | 455,515 | $5.4B | 0.77% | |
| 43 | —PFENEX INC | 632,559 | $5.3B | 0.75% | |
| 44 | —DERMIRA INC | 172,083 | $5.0B | 0.71% | |
| 45 | XLRNACCELERON PHARMA INC | 127,451 | $4.3B | 0.61% | |
| 46 | —AGILE THERAPEUTICS INC | 563,880 | $4.3B | 0.61% | |
| 47 | ATRAGBXATARA BIOTHERAPEUTICS INC | 186,460 | $4.2B | 0.60% | |
| 48 | —LION BIOTECHNOLOGIES INC | 505,941 | $4.1B | 0.58% | |
| 49 | CTMXCYTOMX THERAPEUTICS | 371,636 | $3.8B | 0.54% | |
| 50 | —INTEC PHARMA LTD JERUSALEM | 809,804 | $3.7B | 0.53% | |
| 51 | —IMMUNE DESIGN CORP | 432,990 | $3.5B | 0.50% | |
| 52 | —ONCOBIOLOGICS INC | 1,027,216 | $3.5B | 0.50% | |
| 53 | —ZYNERBA PHARMACEUTICALS INC | 480,501 | $3.3B | 0.47% | |
| 54 | CRVSCORVUS PHARMACEUTICALS INC | 214,132 | $3.1B | 0.43% | |
| 55 | —CONTRAFECT CORP | 840,966 | $2.4B | 0.34% | |
| 56 | —APTOSE BIOSCIENCES INC | 990,579 | $2.4B | 0.34% | |
| 57 | —LIPOCINE INC NEW | 751,296 | $2.3B | 0.32% | |
| 58 | SNDXSYNDAX PHARMACEUTICALS INC | 214,419 | $2.1B | 0.30% | |
| 59 | AGIOAGIOS PHARMACEUTICALS INC | 50,000 | $2.1B | 0.30% | |
| 60 | GLYCEURGLYCOMIMETICS INC | 287,031 | $2.1B | 0.30% | |
| 61 | 2L9BLUEPRINT MEDICINES CORP | 101,226 | $2.0B | 0.29% | |
| 62 | —CELYAD SA | 75,920 | $1.9B | 0.27% | |
| 63 | —CURIS INC | 1,176,645 | $1.8B | 0.26% | |
| 64 | —EPIZYME INC | 159,513 | $1.6B | 0.23% | |
| 65 | RGNXREGENXBIO INC | 156,741 | $1.3B | 0.18% | |
| 66 | —AVEO PHARMACEUTICALS INC | 1,087,715 | $1.0B | 0.15% | |
| 67 | —AQUINOX PHARMACEUTICALS INC | 151,838 | $1.0B | 0.14% | |
| 68 | —TETRALOGIC PHARMACEUTICALS C | 5,000,000 | $856.0M | 0.12% | |
| 69 | AM6AMICUS THERAPEUTICS INC | 151,838 | $829.0M | 0.12% | |
| 70 | ASNDASCENDIS PHARMA A S | 62,254 | $826.0M | 0.12% | |
| 71 | PVCTPROVECTUS BIOPHARMACEUTICALS | 2,226,961 | $824.0M | 0.12% | |
| 72 | —GENVEC INC | 1,190,650 | $682.0M | 0.10% | |
| 73 | —THRESHOLD PHARMACEUTICALS INC | 1,012,255 | $643.0M | 0.09% | |
| 74 | —HTG MOLECULAR DIAGNOSTICS IN | 203,464 | $529.0M | 0.08% | |
| 75 | NSTGEURNANOSTRING TECHNOLOGIES INC | 40,490 | $510.0M | 0.07% | |
| 76 | —NEOS THERAPEUTICS INC | 50,613 | $470.0M | 0.07% | |
| 77 | —PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $414.0M | 0.06% | |
| 78 | —INVUITY INC | 34,200 | $326.0M | 0.05% | |
| 79 | —APPLIED GENETIC TECHNOL CORP | 17,321 | $245.0M | 0.03% | |
| 80 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 25,307 | $206.0M | 0.03% | |
| 81 | —ONCOBIOLOGICS INC | 416,666 | $192.0M | 0.03% | |
| 82 | —ONCOBIOLOGICS INC | 416,666 | $187.0M | 0.03% | |
| 83 | —CELLECTAR BIOSCIENCES INC | 53,649 | $185.0M | 0.03% | |
| 84 | —CELLECTAR BIOSCIENCES INC | 52,999 | $29.0M | 0.00% |